Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Loncastuximab Tesirin 75, diffuse large B-non-Hodgkin Lymphoma, cycle 3+

Protocol-ID: 2230 V1.0 (Mini), LONTES75, DLBCL, C3+

Indication(s)

  • NHL, B-Cell Type, Diffuse Large Cell; ICD-10 C83.3

Links

  • Prescribing information for Loncastuximab Tesirin (ZYNLONTA) (FDA) [URL]
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 21.04.2023